Cargando…
Sustained impact of subcutaneous immunotherapy among patients with allergic rhinitis who experienced treatment delay due to the COVID‐19 pandemic: A multicenter, two‐arm, real‐world study
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886642/ https://www.ncbi.nlm.nih.gov/pubmed/35251592 http://dx.doi.org/10.1002/clt2.12122 |
_version_ | 1784660710657097728 |
---|---|
author | Zhou, Suizi Liu, Yibin Xue, Jianrong Tang, Jun Yu, Qingqing Qu, Shenhong Zhang, Shaojie Mo, Binyu Li, Jihui Liu, Yinhong Yang, Yueying Wang, De‐Yun Qiu, Qianhui |
author_facet | Zhou, Suizi Liu, Yibin Xue, Jianrong Tang, Jun Yu, Qingqing Qu, Shenhong Zhang, Shaojie Mo, Binyu Li, Jihui Liu, Yinhong Yang, Yueying Wang, De‐Yun Qiu, Qianhui |
author_sort | Zhou, Suizi |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8886642 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88866422022-03-04 Sustained impact of subcutaneous immunotherapy among patients with allergic rhinitis who experienced treatment delay due to the COVID‐19 pandemic: A multicenter, two‐arm, real‐world study Zhou, Suizi Liu, Yibin Xue, Jianrong Tang, Jun Yu, Qingqing Qu, Shenhong Zhang, Shaojie Mo, Binyu Li, Jihui Liu, Yinhong Yang, Yueying Wang, De‐Yun Qiu, Qianhui Clin Transl Allergy Letter John Wiley and Sons Inc. 2022-03-01 /pmc/articles/PMC8886642/ /pubmed/35251592 http://dx.doi.org/10.1002/clt2.12122 Text en © 2022 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter Zhou, Suizi Liu, Yibin Xue, Jianrong Tang, Jun Yu, Qingqing Qu, Shenhong Zhang, Shaojie Mo, Binyu Li, Jihui Liu, Yinhong Yang, Yueying Wang, De‐Yun Qiu, Qianhui Sustained impact of subcutaneous immunotherapy among patients with allergic rhinitis who experienced treatment delay due to the COVID‐19 pandemic: A multicenter, two‐arm, real‐world study |
title | Sustained impact of subcutaneous immunotherapy among patients with allergic rhinitis who experienced treatment delay due to the COVID‐19 pandemic: A multicenter, two‐arm, real‐world study |
title_full | Sustained impact of subcutaneous immunotherapy among patients with allergic rhinitis who experienced treatment delay due to the COVID‐19 pandemic: A multicenter, two‐arm, real‐world study |
title_fullStr | Sustained impact of subcutaneous immunotherapy among patients with allergic rhinitis who experienced treatment delay due to the COVID‐19 pandemic: A multicenter, two‐arm, real‐world study |
title_full_unstemmed | Sustained impact of subcutaneous immunotherapy among patients with allergic rhinitis who experienced treatment delay due to the COVID‐19 pandemic: A multicenter, two‐arm, real‐world study |
title_short | Sustained impact of subcutaneous immunotherapy among patients with allergic rhinitis who experienced treatment delay due to the COVID‐19 pandemic: A multicenter, two‐arm, real‐world study |
title_sort | sustained impact of subcutaneous immunotherapy among patients with allergic rhinitis who experienced treatment delay due to the covid‐19 pandemic: a multicenter, two‐arm, real‐world study |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886642/ https://www.ncbi.nlm.nih.gov/pubmed/35251592 http://dx.doi.org/10.1002/clt2.12122 |
work_keys_str_mv | AT zhousuizi sustainedimpactofsubcutaneousimmunotherapyamongpatientswithallergicrhinitiswhoexperiencedtreatmentdelayduetothecovid19pandemicamulticentertwoarmrealworldstudy AT liuyibin sustainedimpactofsubcutaneousimmunotherapyamongpatientswithallergicrhinitiswhoexperiencedtreatmentdelayduetothecovid19pandemicamulticentertwoarmrealworldstudy AT xuejianrong sustainedimpactofsubcutaneousimmunotherapyamongpatientswithallergicrhinitiswhoexperiencedtreatmentdelayduetothecovid19pandemicamulticentertwoarmrealworldstudy AT tangjun sustainedimpactofsubcutaneousimmunotherapyamongpatientswithallergicrhinitiswhoexperiencedtreatmentdelayduetothecovid19pandemicamulticentertwoarmrealworldstudy AT yuqingqing sustainedimpactofsubcutaneousimmunotherapyamongpatientswithallergicrhinitiswhoexperiencedtreatmentdelayduetothecovid19pandemicamulticentertwoarmrealworldstudy AT qushenhong sustainedimpactofsubcutaneousimmunotherapyamongpatientswithallergicrhinitiswhoexperiencedtreatmentdelayduetothecovid19pandemicamulticentertwoarmrealworldstudy AT zhangshaojie sustainedimpactofsubcutaneousimmunotherapyamongpatientswithallergicrhinitiswhoexperiencedtreatmentdelayduetothecovid19pandemicamulticentertwoarmrealworldstudy AT mobinyu sustainedimpactofsubcutaneousimmunotherapyamongpatientswithallergicrhinitiswhoexperiencedtreatmentdelayduetothecovid19pandemicamulticentertwoarmrealworldstudy AT lijihui sustainedimpactofsubcutaneousimmunotherapyamongpatientswithallergicrhinitiswhoexperiencedtreatmentdelayduetothecovid19pandemicamulticentertwoarmrealworldstudy AT liuyinhong sustainedimpactofsubcutaneousimmunotherapyamongpatientswithallergicrhinitiswhoexperiencedtreatmentdelayduetothecovid19pandemicamulticentertwoarmrealworldstudy AT yangyueying sustainedimpactofsubcutaneousimmunotherapyamongpatientswithallergicrhinitiswhoexperiencedtreatmentdelayduetothecovid19pandemicamulticentertwoarmrealworldstudy AT wangdeyun sustainedimpactofsubcutaneousimmunotherapyamongpatientswithallergicrhinitiswhoexperiencedtreatmentdelayduetothecovid19pandemicamulticentertwoarmrealworldstudy AT qiuqianhui sustainedimpactofsubcutaneousimmunotherapyamongpatientswithallergicrhinitiswhoexperiencedtreatmentdelayduetothecovid19pandemicamulticentertwoarmrealworldstudy |